atromentin has been researched along with vialinin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, N; Ashida, H; Makiuchi, M; Namiki, D; Onose, J; Sugaya, K; Yoshioka, Y | 1 |
| Bailly, C | 1 |
1 review(s) available for atromentin and vialinin a
| Article | Year |
|---|---|
Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Fungi; Humans; Peptide Hydrolases; Terphenyl Compounds; Ubiquitin-Specific Proteases | 2022 |
1 other study(ies) available for atromentin and vialinin a
| Article | Year |
|---|---|
Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity.
Topics: Agaricales; Animals; Cell Line; Humans; Kinetics; Protein Binding; Rats; Recombinant Proteins; SUMO-1 Protein; Terphenyl Compounds; Tumor Necrosis Factor-alpha | 2016 |